Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a Phase 3 RCT registration with no posted results; the study is actively recruiting and outcome data are not yet available for clinical interpretation.
This is a Phase 3 trial registration with no results reported; it describes a planned study of sacituzumab tirumotecan in early breast cancer, currently recruiting.
This is an active Phase 1/2 trial registration with no results posted; it describes planned enrollment and safety/efficacy endpoints but reports no outcome data.